Medtronic Impact Report Highlights More Than 82 Million Patients Served Worldwide in Fiscal Year 2026
Key Highlights
- ➤82 million-plus patients served worldwide in FY26
- ➤$2.9 billion invested in research and development
- ➤315-plus product approvals achieved in major markets
- ➤Hugo robotic-assisted surgery system received FDA clearance
- ➤68% reduction in Scope 1 and 2 intensity versus FY20 baseline
Expert Statements
Geoff Martha, Chairman and CEO of Medtronic
“What comes next is continuing to advance robotics, AI, and connected technologies so more patients in more places can benefit.”
Geoff Martha, Chairman and CEO of Medtronic
“The goal is simple: better care, better outcomes, and broader access.”
NORTHAMPTON, MA / ACCESS Newswire / October 6, 2026 / Medtronic, a global leader in healthcare technology, today released its fiscal year 2026 (FY26) Impact Report titled "Precision with Purpose," bringing to life the progress behind its impact goals. In a year shaped by innovation and execution, Medtronic served more than 82 million patients worldwide, invested $2.9 billion in research and development, and achieved more than 315 product approvals in major markets, including FDA clearance of the Hugo™ robotic-assisted surgery system. Together, these initiatives expand access to care and help address critical unmet health needs.
"What comes next is continuing to advance robotics, AI, and connected technologies so more patients in more places can benefit," said Geoff Martha, Medtronic chairman and CEO. "The goal is simple: better care, better outcomes, and broader access."
Get started
Create a free account to read the full story.